Figure 1.
IGSF9 level is detected by flow cytometry. (A-E) IGSF9 levels are detected by flow cytometry in T cells, B cells, and myeloid cells from healthy donors (n = 10), CD33+/CD13+ leukemia cells (n = 27), CD34+/CD117+ leukemia stem cells (n = 15), umbilical cord blood (n = 5), and AML cell lines including THP-1, MV4-11, Molm13, and U937 cells. APC, allophycocyanin; FITC, fluorescein isothiocyanate; PBMC, peripheral blood mononuclear cell.

IGSF9 level is detected by flow cytometry. (A-E) IGSF9 levels are detected by flow cytometry in T cells, B cells, and myeloid cells from healthy donors (n = 10), CD33+/CD13+ leukemia cells (n = 27), CD34+/CD117+ leukemia stem cells (n = 15), umbilical cord blood (n = 5), and AML cell lines including THP-1, MV4-11, Molm13, and U937 cells. APC, allophycocyanin; FITC, fluorescein isothiocyanate; PBMC, peripheral blood mononuclear cell.

or Create an Account

Close Modal
Close Modal